With box warnings

Without box warnings

Branded

Generic

2 results

opdivo
(nivolumab)
E.R. Squibb & Sons, L.L.C.
Usage: OPDIVO is indicated for the treatment of various cancers, including unresectable/metastatic melanoma, neoadjuvant and adjuvant non-small cell lung cancer, metastatic non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma, classical Hodgkin lymphoma, and others. It is used in different combinations and settings based on the cancer type.
yervoy
(ipilimumab)
E.R. Squibb & Sons, L.L.C.
Usage: YERVOY is indicated for treating unresectable or metastatic melanoma, adjuvant melanoma post-resection, advanced renal cell carcinoma, microsatellite instability-high colorectal cancer, hepatocellular carcinoma, metastatic non-small cell lung cancer, malignant pleural mesothelioma, and unresectable esophageal cancer, often in combination with nivolumab.

Medications for Esophageal Carcinoma

opdivo